Online Course

CARE 2021


Expires Oct 6, 2024

Program Information

CME: 20.0    MOC: 20.0

Assess your rheumatology medical knowledge and enhance your patient care. With CARE 2021 you receive:

  • 60 case-based, multiple-choice questions with in-depth answer rationales
  • Images and educational links
  • 20.0 ABIM MOC points and 20.0 AMA PRA Category 1 Credit(s)™ with a passing score of 70% or higher

Target Audience
Rheumatologists, physicians, healthcare providers who care for patients with rheumatic diseases, and those interested or engaged in rheumatology research.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Recognize clinical presentations of rheumatologic conditions
  • Select appropriate tests in the diagnosis, staging, or follow-up of rheumatologic conditions
  • Recommend appropriate management for rheumatologic conditions
  • Assess risk in rheumatologic conditions
  • Understand pathophysiology and basic science relevant to the care of patients with rheumatologic conditions

Registration Fees

  • Member - $180
  • Non-Member - $300
  • FIT Members - $99
  • FIT Nonmembers - $150
  • Program Directors - $99 (contact to receive a discount code for the reduced rate)

CME and MOC Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this online activity for a maximum of 20.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity you provide the ACR permission to share completion data with the ACCME and the certifying board(s).


Faculty and Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at

Nature of Financial Relationships

Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial relationships with ineligible companies any financial or other relationship(s) with an ineligible company including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
  7. Independent contractor
  8. Ownership interest
  9. Royalties
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Other financial or material support

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

The CARE Development Group and faculty reported the following disclosures.

CARE Development Group Members
The following CARE Development Group members have no relevant financial relationship(s) with ineligible companies to disclose.

  • Alan Erickson, MD
  • Mark Fisher, MD
  • Rumey Ishizawar, MD
  • Deana Lazaro, MD
  • Jennifer Medlin, MD
  • Angela Robinson, MD
  • Amanda Sammut, MD
  • Joel Hirsh, MD
  • Jonathan Cheah, MD
  • Lisa Davis, MD
  • Richa Dhawan, MD
  • Justus Fiechtner, MD
  • Vikram Garg, MD
  • Arundathi Jayatilleke, MD
  • Katharine Moore, MD
  • Abhishek Nandan, MD
  • Luc Nguyen, MD
  • Yevgeniy Popov, DO
  • Chokkalingam Siva, MD
  • Jennifer Stichman, MD
  • Kai Sun, MD
  • Huzaefah Syed, MD
  • Nicole Walton, MD

The following planning committee members have relevant financial relationship(s) with ineligible companies to disclose.

The following planning committee members have relevant financial relationship(s) with ineligible companies to disclose.

  • Meenakshi Jolly, MD, MS - Pfizer2, Eli Lily7, BMS7, Aurinia7, Celgene7
  • Francesco Boin, MD - Leadiant Biosciences2,5
  • Rebecca Manno, MD - Genentech5, Sanofi5, Novartis9

The following Planning Committee members have relevant financial relationship(s) with ineligible companies to disclose.

  • Anisha Dua, MD - Abbvie5,6; Novartis5,6; Chemocentryx5,6
  • Bryant England, MD - Boehringer Ingelheim5
  • Nina Ramessar, MD – GlaxoSmithKline8
  • Beth Rubinstein, MD - Amgen1; General Electric Co1; Bristol Myers Squibb1; Exagen8; Gilead6; Boehringer Ingelheim6; Flexion8; Horizon8
  • Matthew Carroll, MD, FACP, FACR - Exagen8; Gilead6; Boehringer Ingelheim6; Flexion8; Horizon8
  • Prateek Gandiga, MD, FACP - Kezar Pharmaceuticals
  • Fotios Koumpouras, MD - GSK5,6; Celgene8; Astra Zeneca9 (advisor)

*All of the relevant financial relationships listed for these individuals have been mitigated.

Corporate Support

The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives. See supporters, guidelines, and benefits of supporting the ACR.

© 2022 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us